TY  - GEN
AU  - Ferreri,A J M
AU  - Sassone,M
AU  - Kiesewetter,B
AU  - Govi,S
AU  - Scarfò,L
AU  - Donadoni,G
AU  - Raderer,M
TI  - High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial
SN  - 1569-8041
PY  - 2016///0421
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Clarithromycin
KW  - Colorectal Neoplasms
KW  - Disease-Free Survival
KW  - Eye Neoplasms
KW  - Female
KW  - Humans
KW  - Lymphoma, B-Cell, Marginal Zone
KW  - Male
KW  - Middle Aged
KW  - Mouth Neoplasms
KW  - Neoplasms, Multiple Primary
KW  - Salvage Therapy
KW  - Skin Neoplasms
KW  - Stomach Neoplasms
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1093/annonc/mdv214
ER  -